Lord, Abbett & Co. LLC Seres Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$5.46 - $22.6 $4.77 Million - $19.8 Million	-874,124 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.46 - $24.36 $3.21 Million - $4.24 Million	174,075 Added 24.87%	874,124 $20.8 Million
Q1 2021 May 11, 2021	SELL	$17.66 - $28.92 $11.1 Million - $18.2 Million	-627,848 Reduced 47.28%	700,049 $14.4 Million
Q4 2020 Feb 09, 2021	BUY	$23.25 - $37.73 $23.4 Million - $38 Million	1,006,953 Added 313.75%	1,327,897 $32.5 Million
Q3 2020 Nov 12, 2020	BUY	$3.74 - $28.74 $1.2 Million - $9.22 Million	320,944 New	320,944 $9.09 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.